Priapism – A rare side effect of alpha blockers: Report of 2 cases and literature review
Tài liệu tham khảo
Montague Drogo, 2003, American Urological Association guideline on the management of priapism, J Urol, 170, 1318, 10.1097/01.ju.0000087608.07371.ca
Broderick, 2010, Priapism: pathogenesis, epidemiology, and management, J Sex Med, 7, 476, 10.1111/j.1743-6109.2009.01625.x
Walsh, 2002, Physiology of penile erection and pathophysiology of erectile dysfunction and priapism, Campbell's Urol, 1610
Hofner, 1999, Tamsulosin 0.4mg once daily: effect on sexual function in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction, Eur Urol, 36, 335, 10.1159/000019996
Carruthers, 1994, Adverse effects of alpha 1-adrenergic blocking drugs, Drug Saf, 11, 12, 10.2165/00002018-199411010-00003
Fonseca, 2015, The diagnosis and treatment of lower urinary tract symptoms due to benign prostatic hyperplasia with alpha-blockers: focus on silodosin, Clin Drug Investig, 35, 7, 10.1007/s40261-014-0257-3
Tatemichi, 2006, Alpha1-adrenoceptor subtype selectivity and organ specificity of silodosin (KMD-3213), Yakugaku Zasshi, 209
Spagnul, 2011, Adrenergic alpha-blockers: an infrequent and overlooked cause of priapism, Int J Impot Res, 23, 95, 10.1038/ijir.2011.12
Marconi, 2019, Priapism induced by use of tamsulosin: a case report and review of the literature, Arch Ital Urol Androl, 91, 10.4081/aiua.2019.3.193
Kilinc, 2009, Partial priapism secondary to tamsulosin: a case report and review of the literature, Andrologia, 41, 199, 10.1111/j.1439-0272.2008.00908.x
Khater U, Ramasamy R, Shah HN. Tamsulosin-induced priapism: report of two cases and review of literature, J Endourol Case Rep 2020;X:1–3. doi:10.1089/cren.2019.0157.
Banos, 1989, Drug-induced priapism, its aetiology, incidence and treatment, Med Toxicol Adverse Drug Exp, 4, 46
Barry, 1976, Priapism: treatment with corpus cavernosum to dorsal vein of penis shunts, J Urol, 116, 754, 10.1016/S0022-5347(17)58998-3
Furyk, 2016, Distal ureteric stones and tamsulosin: a double-blind, placebo-controlled, randomized, multicenter trial, Ann Emerg Med, 67, 86, 10.1016/j.annemergmed.2015.06.001